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Abstract
Background: Neonatal mice developed neurological disease and pulmonary dysfunction after an infection with a
mouse-adapted human Enterovirus 71 (EV71) strain MP4. However, the hallmark of severe human EV71 infection,
pulmonary edema (PE), was not evident.
Methods: To test whether EV71-induced PE required a proinflammatory cytokine response, exogenous pro-
inflammatory cytokines were administered to EV71-infected mice during the late stage of infection.
Results: After intracranial infection of EV71/MP4, 7-day-old mice developed hind-limb paralysis, pulmonary
dysfunction, and emphysema. A transient increase was observed in serum IL-6, IL-10, IL-13, and IFN-g, but not
noradrenaline. At day 3 post infection, treatment with IL-6, IL-13, and IFN-g provoked mild PE and severe
emphysema that were accompanied by pulmonary dysfunction in EV71-infected, but not herpes simplex virus-1
(HSV-1)-infected control mice. Adult mice did not develop PE after an intracerebral microinjection of EV71 into the
nucleus tractus solitarii (NTS). While viral antigen accumulated in the ventral medulla and the NTS of intracerebrally
injected mice, neuronal loss was observed in the ventral medulla only.
Conclusions: Exogenous IL-6, IL-13, and IFN-g treatment could induce mild PE and exacerbate pulmonary
abnormality of EV71-infected mice. However, other factors such as over-activation of the sympathetic nervous
system may also be required for the development of classic PE symptoms.
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Background
Enterovirus 71 (EV71), a highly neurotropic, positive-sense
single-stranded RNA virus, belongs to the Enterovirus
genus of Picornaviridae family. In general, EV71 infections
are mild, such as hand, foot, and mouth disease and her-
pangina in young children. However, central nervous sys-
tem (CNS) infections with life-threatening pulmonary and
cardiac complications have occurred [1]. EV71 has been
regarded as the most important neurotropic enterovirus
since the effective control of the poliovirus (PV). More
than a dozen severe EV71 outbreaks have been reported
worldwide since it was first recognized in California in
1969 [2].
Pulmonary edema (PE) and subsequent rapid onset
cardiopulmonary failure are hallmarks of EV71 induced
mortality [3]. EV71-induced PE has been considered neu-
rogenic in origin, as it has been observed to be associated
with brainstem encephalitis without signs of pneumonia
and myocarditis [4,5]. Most EV71 patients with PE
presented symptoms of autonomic nervous system dysre-
gulation and sympathetic excitement, suggesting hemody-
namic alterations may underlie the disease mechanism of
EV71-induced PE. Elevated levels of plasma catecholamine
and epinephrine, coagulative myocytolysis, and myocardial
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symptoms [6]. Researchers have speculated that systemic
and local proinflammatory responses resulting from
EV71-related inflammation and brain damage are involved
in the development of PE in EV71 patients [7]. However,
in one previous study, only 1 out of the 5 PE patients
showed systolic hypertension and elevated pulmonary
artery pressure [5].
Our previous studies showed that a mouse-adapted
EV71 strain, EV71/MP4, could experimentally infect
laboratory mice via oral (p.o.), intramuscular, and intra-
cranial (i.c.) inoculation routes, resulting in CNS infec-
tion and death [8]. Clinically, the animals developed
neurological disease and pulmonary dysfunction. Viral
antigens were concentrated in the cerebellar peduncle of
the brainstem beneath the cerebellum and the anterior
horn regions of the spinal cord, but not in the heart or
lungs [9]. The CNS exhibited obvious pathology. How-
ever, while the lungs exhibited emphysema, PE was not
observed. Our results suggested that CNS infection alone
was not sufficient for the development of PE in EV71-
infected mice. In this study, we demonstrated that sys-
temic administration of proinflammatory cytokines IL-6,
IL-13, and IFN-g could exacerbate pulmonary abnormal-
ities and induce mild PE in EV71-infected mice.
Methods
Cells and viruses
Rhabdomyosarcoma (RD) cells (American Type Culture
Collection, Manassas, VA) were maintained in Dulbec-
co’s modified Eagle’s medium (DMEM) containing 10%
fetal bovine serum, 2 mM L-glutamine, penicillin and
streptomycin. Vero cells (ATCC) were maintained in
DMEM containing 5% newborn calf serum, penicillin
and streptomycin. Mouse-adapted EV71 strain MP4 [8]
was propagated in RD cells. Working stocks contained 4
×1 0
7 PFU/ml. MP4 strains were tested by monoclonal
antibodies for EV71 (mAb3324), EV71/coxsackievirus
A16 (mAb3323), coxsackievirus A24 (mAb3302), cox-
sackievirus B3 (mAb3306), echovirus 9 (mAb3313), PV
type 1 (mAb3331), PV type 2 (mAb3332), and PV type
3 (mAb3335) (all from Chemicon, Temecula, CA) using
indirect immunofluorescence staining of infected RD
cell cultures, and RT-PCR using specific primers for
EV71. HSV-1/KOS, a clinical isolate strain of human
simplex virus-1 (HSV-1) (courtesy of Dr. Shun-Hua
Chen, National Cheng Kung University, College of Med-
icine, Tainan, Taiwan) was grown in Vero cells.
Animal experiments
Specific-pathogen-free, 7-day-old ICR mice (Laboratory
Animal Center, National Cheng Kung University, College
of Medicine) were i.c. injected with 10 μlo fE V 7 1 / M P 4
(4 × 10
5 PUF/mouse) or HSV-1/KOS (2 × 10
2 PFU/
mouse) through the fontanelles using a 26-gauge needle.
C o n t r o lm i c ew e r eg i v e nc u l t u r em e d i u m .T os y s t e m i -
cally increase proinflammatory cytokine levels, mice were
intraperitoneally (i.p.) injected at three days post-inocula-
tion with recombinant mouse IL-6, IL-13, and IFN-g
(0.05, 0.15, and 0.8 μg/mouse, respectively) (R&D, Min-
neapolis, MN) 2 or 3 times within 48 h. Control mice
w e r eg i v e nb o v i n es e r u ma l b u m i n( B S A ) .M i c ew e r e
observed twice daily for clinical signs and mortality. Lung
function and body weight monitored daily for one week.
Lung weight/body weight analysis, histopathology, and
immunohistochemistry were performed after these
experiments. For i.c. microinjection, EV71/MP4 was
bilaterally microinjected into the nucleus tractus solitarii
(NTS; AP-7.72 mm, LM+/-0.6 mm, DV-5.5 mm) of 8-
week-old ICR mice in a volume of 0.2 μl( 3×1 0
7 PFU/
ml) over 10 min through a 27-gauge stainless steel can-
nula connected to a 10-μl Hamilton syringe (Hamilton,
Reno, NV) driven by an injection pump (Legato 200 ser-
ies, KD Scientific, MA). Mice were observed twice daily
for clinical signs and mortality for 5 days. Clinical disease
w a ss c o r e da sf o l l o w s :0 ,h e a l t h y ;1 ,r u f f l e df u ra n d
hunchbacked appearance; 2, wasting; 3, limb weakness; 4,
limb paralysis; 5, moribund and death. The Institutional
Animal Care and Use Committee approved all animal
protocols.
Unrestrained whole-body plethysmograph
Pulmonary functions of EV71- and HSV-1-infected mice
were measured in unrestrained animals using a whole-
body plethysmograph (Buxco, Troy, NY). Readings were
collected for 3 min after 3 min of resting in the chamber.
Cytokine and noradrenaline levels
After anesthetization with pentobarbital sodium (Nembu-
tal; Abbott Laboratories, North Chicago, IL), blood was
collected after axilla dissection. The levels of IL-6, IL-10,
IL-13, and IFN-g in serum and noradrenaline in plasma of
EV71-infected mice were determined using ELISA kits
(ELISA DuoSet, R&D, Minneapolis, MN) and a noradre-
naline EIA kit (LDN, Nordhorn, Germany), respectively
according to the manufacturer’s instructions. The detec-
tion limits for IL-6, IL-10, IL-13, IFN-g, and noradrenaline
were 15.6, 31.25, 62.5, 31.25, and 0.027 pg/ml, respectively.
Measurement of wet lung weight
Changes in vascular permeability in lungs were deter-
mined by measuring the increment of wet lung weight.
Individual lung lobes were removed, blot-dried on gauze,
and weighed using a balance with accuracy to 0.0001
gram. Data were expressed as the ratio of total wet lung
weight to body weight.
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Animals were perfused with isotonic saline containing
EDTA. The whole brains and lungs were removed and
weighed. Half of the tissues were immersion fixed in 10%
buffered formalin for 48 h, bisected, embedded in paraffin,
and stained with hematoyxlin and eosin (H & E) or Nissl
stain. The remaining tissue samples were frozen in a liquid
nitrogen-cold hexane bath in 100% OCT compound
( M i l e s ,E l k h a r t ,I N ) .A l ls a m p l e sw e r es t o r e da t- 7 0 °C
until assayed.
Immunostaining
The presence of EV71 virions in cryosections of frozen tis-
sues (8 to 10 μm; Leica CM1800, Wetzlar, Germany) was
v i s u a l i z e db yap r e v i o u s l yd e s c r i b e dm e t h o d[ 8 ] .I na d d i -
tion, neuronal cells were identified by staining with mono-
clonal anti-NeuN antibody (Sigma-Aldrich, St. Louis, MO)
as previously described [10]. Positively stained cells were
enumerated by counting at least 10 fields and expressed as
the average number per field.
Statistical analysis
The clinical scores, lung weight/body weight ratio, and
numbers of EV71-positive and NeuN-positive cells were
analyzed using either the nonparametric one-way analysis
of variance (ANOVA) or Mann-Whitney U tests. The
results are expressed as means ± standard errors of the
means (S.E.M.). A P value of < 0.05 was considered
significant.
Results
EV71 infection provoked proinflammatory cytokine but
not noradrenaline production in mice
Previous findings suggested that proinflammatory cyto-
kines including IL-6, IL-10, IL-13, and IFN-g were asso-
ciated with the development of PE in patients infected
with EV71 [7], we thus measured these cytokines in an
mouse model of EV71 infection developed by in our
laboratory [8]. As expected, after an i.c. inoculation of
EV71 (4 × 10
5 PFU/mouse), 7-day-old mice did not gain
weight and developed clinical symptoms with diffuse
emphysema but no evidence of PE in the lung (see Addi-
tional File 1, Figure S1). In general, most of the animals
died at day 5 post inoculation. There was a significant
increase in serum proinflammatory cytokines including
IL-6, IL-10, and IFN-g but not IL-13 (Figure 1A). Specifi-
cally, IFN-g was detected in serum as early as 1 day post
infection and remained elevated at a high level for up to
6 days in the survivors. Increased levels of IL-6 were
noted 3 days post infection. Elevated IL-10 was only
detected at and after 5 days post infection. Notably, there
was no increase in the concentration of IL-13 in the
serum after EV71 infection. Plasma noradrenaline levels
of EV71-infected mice were not statistically difference
than those of control mice (Figure 1B).
Cytokine treatment slightly exacerbated the clinical
disease and pulmonary dysfunction of EV71-infected mice
To assess whether an insufficient amount of proinflam-
matory cytokines accounted for the absence of PE in
EV71-infected mice, we i.p. injected recombinant mouse
IL-6 (0.05 μg/mouse), IL-13 (0.15 μg/mouse), and IFN-g
(0.8 μg/mouse) to mice 3 days after an i.c. inoculation
of EV71 (two doses within 48 h). At this time the ani-
mals developed mild clinical symptoms with the pre-
sence of virus in the CNS. All the mock-infected BSA-
treated mice gained weight normally (Figure 2A) with-
out pulmonary dysfunction (Figure 2B). Exogenous IL-6,
IL-13, and IFN-g treatments neither affected the body
weight, nor caused illness of the mock-infected mice. As
expected, the EV71-infected mice exhibited weight loss,
but weight loss was not affected by the cytokine treat-
ments (Figure 2A). Although severe limb weakness and
paralysis were observed in some of the infected mice at
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Figure 1 Intracranial inoculation of EV71 transiently increased
proinflammatory cytokines in mice, but not noradreanline.
Seven-day-old ICR mice (n = 24) were intracranially inoculated with
or without EV71/MP4 strain (4 x 10
5 PFU/mouse). Serum or plasma
samples were collected at indicated post-inoculation time points.
Concentrations of IL-6, IL-10, IL-13, and IFN-g (A) and noradrenaline
(B) were determined. Data represent means ± S.E.M.
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Page 3 of 9days 3 and 4 after infection, there was no significant dif-
ference in clinical score between the EV71-infected
BSA-treated mice and EV71-infected cytokine-treated
mice. Conversely, cytokine treatment exacerbated the
pulmonary dysfunction of EV71-infected mice as com-
pared with EV71-infected BSA-treated mice at day 4
post inoculation (Figure 2B).
Cytokine treatment elevated lung weight and induced
mild pulmonary edema in EV71- but not herpes simplex
virus-infected mice
Weight loss in EV71-infected mice resulted in increased
lung weight/body weight ratios, as compared with non-
infected control mice (P = 0.0054, Figure 3A). Exogen-
ous cytokine treatment (IL-6, IL-13, and IFN-g,2d o s e s
within 48 h) increased the lung weight/body weight
ratio of EV71-infected mice as compared with EV71-
infected control mice (P = 0.0318, Figure 3A). Diffuse
congestion and interlobular edema were noted grossly
(Figure 3C). Histopathologically, EV71-infected mice
with cytokine treatment exhibited moderate to severe
emphysema (>75% alveoli), lung congestion, and mild
PE as characterized by the accumulation of eosinophilic
and homogenous exudates in alveolar spaces and
bronchioles (approximately 12 per 100 alveoli) (Figure
3D). Increasing the dosages of the three cytokines (3
times within 48 h) or IL-13 alone exacerbated the pul-
monary dysfunction (see Additional File 2, Figure S2),
but did not further increase the lung weight/body
weight ratio of the EV71-infected mice (Figure 3A). Co-
administration of IL-6 and IFN-g increased lung weight/
body weight ratio of infected mice in a way similar to
that of the three cytokines treatment (Figure 3A). To
clarify whether the observed effects were specific for
EV71 infection, mice were i.c. infected with HSV-1/KOS
(2 × 10
2 PFU/mouse) prior to the administration of IL-
6, IL-13, and IFN-g. HSV-1 is a neurotropic virus and
its infection is known to cause diffuse encephalitis in
mice, mainly in tissues of the cerebrum and cerebellu
[11]. HSV-1-infected animals developed pulmonary dys-
function with an increase in PIF, MV, and TV as com-
pared to EV71-infected mice before cytokine treatment
(Figure 2B). HSV-1-infected mice also exhibited lung
emphysema (Figure 3D) with much milder symptoms
than those of EV71-infected mice. Exogenous IL-6, IL-
13, and IFN-g treatment neither increased the lung
weight/body weight ratio (Figure 3B), exacerbated pul-
monary dysfunction (Figure 2B), nor induced PE (Figure
3C and 3D) in HSV-1-infected mice.
EV71 caused neuronal damage in brain regions not
associated with the development of pulmonary edema
To test whether EV71 infection of the NTS was a prere-
quisite for PE development, we directly i.c. inoculated
EV71 into the NTS of adult mice. The animals developed
neither clinical disease nor PE over the course of the
experiment (data not shown). Immunostaining showed
that EV71-positive cells accumulated at the ventral
medulla (VM) over time (Figure 4A and 4B). This obser-
vation positively correlated with a decrease in the num-
bers of NeuN-positive cells in this area (Figure 4A and
4D). EV71-positive cells were also detected at the NTS
with very few staining outside these areas at day 5 after
inoculation (Figure 4C). Surprisingly, the numbers of
NeuN-positive cells in the NTS remained unchanged
after EV71 inoculation (Figure 4E). These results indi-
cated that EV71 established a lytic infection in the VM
and a non-lytic infection in the NTS.
Discussion
In the course of the development of a mouse model of
human EV71 infection, we demonstrated that EV71
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Figure 2 Proinflammatory cytokine treatment exacerbated
pulmonary dysfunction in EV71-infected, but not HSV-1-infected
mice. Seven day-old ICR mice (n = 12) were intracranially inoculated
with EV71 (4 × 10
5 PFU/mouse) or HSV-1/KOS (2 × 10
2 PFU/mouse)
followed by an intraperitoneal injection of IL-6, IL-13, and IFN-g at days
3 and 4 post inoculation (arrows). The body weights (A) and
pulmonary functions of mice were monitored daily (B). Ctrl: culture
medium; BSA: bovine serum albumin; Cyt: IL-6, IL-13, and IFN-g
treatment; PIF: peak of inspiratory flow; PEF: peak of expiratory flow;
MV: minute volume; TV: tidal volume. Data represent means ± S.E.M. *,
P < 0.05 and **, P < 0.0001 as compared to BSA-treatment control. #,
P < 0.01 and ##, P < 0.001 as compared to EV71-infected mice.
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Figure 3 Proinflammatory cytokine treatment increased the lung weight/body weight ratio and induced alveolar exudation of EV71-
infected, but not HSV-1-infected mice. Seven-day-old ICR mice (n = 12) as treated as described in Figure 2. Their lung weight/body weight
ratio was determined (A and B), and lung tissues were collected for gross (C) and histopathological examination (H & E stain) (D) at day 1 after
the cytokine treatment. BSA: mice received BSA only; ×2: mice received 2 doses of cytokines within 48 h; ×3: mice received 3 doses of cytokines
within 48 h. Note interlobular edema (arrow) (C) and eosinophilic, proteinaceous exudation in alveolar spaces with moderate to severe
emphysema in EV71-infected mice with cytokine treatment. Bars: 1.0 mm (left panel), 200 μm (right panel). (D). Data represent means ± S.E.M.
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Figure 4 Microinjection of EV71 to nucleus tractus solitarii resulted in the accumulation of viral antigens in both nucleus tractus
solitarii and ventral medulla with neuronal loss in ventral medulla. EV71/MP4 (3 × 10
7 PFU/ml) was bilaterally microinjected into the
nucleus tractus solitarii (NTS) of 8-week-old ICR mice in a volume of 0.2 μl. Sagittal cryosections of brain tissues were stained with Nissl strain or
anti-EV71 or anti-NeuN antibody (A). Quantification of EV71-positive cells in ventral medulla (VM) (B) and different brain regions (C), and NeuN-
positive cells in VM (D) and NTS (E). CB: cerebellum; black square: remote area; red square: VM area; blue square: NTS. Data represent means ± S.
E.M. of 3 mice with 3 sections per mouse. *, P < 0.001.
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Page 6 of 9could spread from the gastrointestinal tract or muscle to
and accumulate in the CNS, especially in the brainstem
of mice after different routes of inoculation [9]. Follow-
ing neuroinvasion, the animals exhibited paralysis, pul-
monary dysfunction, and death, but did not develop PE,
the hallmark in human EV71 patients with severe com-
plications [12]. In this study, we demonstrated that
EV71-infected mice displayed a cytokine profile that was
distinct from that of human patients. The NTS was not
the CNS target of EV71 infection as viral titer was extre-
mely low in this area of infected mice, which might
explain why PE was absent in the infected animals.
Clinical findings showed that increases in serum IL-1b,
IL-6, IL-10, IL-13, TNF-a,a n dI F N - g were associated
with PE development in EV71 patients [7,13,14]. In this
study, the EV71-infected mice exhibited only a subtle
and transient elevation of serum IL-6, IL-10, and IFN-g.
Thus, the absence of PE in EV71-infected mice might be
attributed to inadequate proinflammatory cytokine levels
of IL-6, IL-13, and IFN-g. Indeed, the introduction of
exogenous IL-6, IL-13, and IFN-g in EV71-infected mice
exacerbated pulmonary dysfunction and resulted in
increases in lung weight/body weight ratio and intra-
alveolar exudation. In addition, treatment with IL-6 and
IFN-g was sufficient for provoking the observed effect.
Both IL-6 and IFN-g are related to PE development via
their effects on endothelial cells and inflammation [15],
[16], and both of these cytokines were important for
microvascular angiogenesis and leakage in an atopic der-
matitis mouse model [17]. Recent animal study indeed
demonstrated the pathological role of IL-6 in the induc-
t i o no ft i s s u ed a m a g ea n dm o r t a l i t yi nE V 7 1 - i n f e c t e d
mice [18]. IL-13 alone exacerbated only pulmonary dys-
function in our EV71-infected mice, which is consistent
with the biological function of the cytokine. IL-13 is a
potent effector cytokine for asthma, as it can directly
cause airway hyperreactivity, mucus over-production,
increased pulmonary vessel permeability, and smooth
muscle hypertrophy, effects that have been shown to con-
tribute to pulmonary dysfunction and respiratory distress
[19]. Taken collectively, our data suggest that elevated
serum IL-6 and IFN-g contribute significantly to PE
development during EV71 infection in mice.
Based on the distribution of viral antigens and viral
genomic sequences, EV71 is likely propagated through-
out the CNS via motor pathways [20]. Our previous
study indicated a retrograde axonal transport of the virus
in neuronal cells [9], which serves as strong evidence that
EV71 preferentially infects certain tissues or cell types in
the CNS. Both histopathological [20] and magnetic reso-
nance imaging studies [21], [22] of EV71 patients with PE
showed that the major CNS lesions were in the posterior
medulla oblongata, pons, midbrain, dentate nuclei of the
cerebellum, and ventral horns of the cervical spinal cord.
In addition, EV71 viral antigens and genomic sequences
were detected primarily in neurons and neuronal pro-
cesses under inflammatory conditions [23]. The fact that
exogenous IL-6, IL-13, and IFN-g worked only in EV71-
infected, but not HSV-1-infected mice, suggests a prere-
quisite for a region-specific CNS infection for PE
development.
Surprisingly, PE did not developed in adult mice after a
direct inoculation of EV71 to the NTS, an area known to
contribute to the development of PE in rats upon injury
[24,25]. In our current study, the neurons in the NTS of
adult mice seemed to be more resistant to EV71 than those
in the ventral medulla. Thus, it is possible that the inability
of EV71 to cause PE was due to the lack of NTS damage
and perhaps neurogenic cardiopulmonary complications.
Besides an over-stimulated proinflammatory response,
sympathetic excitement has been proposed as another
mechanism involved in the development PE in EV71
patients [7]. Imbalances in sympathetic functions have
been observed to cause systemic or pulmonary hyperten-
sion which may contribute to the development of PE due
to hemodynamic alterations and hydrostatic overpressure
in mice [26], other animals [26,27], and human beings
[28,29]. Moreover, neurogenic stimulation may also induce
movement of plasma proteins into the airway lumen in
rats [30]. The plasma noradrenaline levels were not altered
in EV71-infected mice. Thus, it may worthwhile to test the
effects of catecholamine solely or in combination with the
cytokines with regard to PE development.
Collectively, we demonstrated that IL-6, IL-13, and
IFN-g over-stimulation exacerbated pulmonary dysfunc-
tion and clinical symptoms, and provoked a mild PE in
EV71-infected mice. A synergistic proinflammatory cyto-
kine response and damage to specific brain regions, or
more precisely specific neuronal cells, may be necessary
for the development of EV71-induced PE.
Additional material
Additional file 1: Figure 1S. Intracranial inoculation of EV71 resulted
in CNS infection, clinical disease, and emphysema in mice. Seven-
day-old ICR mice (n = 24) were intracranially inoculated with or without
EV71/MP4 strain (4 x10
5 PUF/mouse). Body weight (A) and clinical
disease (B) were then monitored daily after infection. Lung tissues were
collected for general morphological analysis (H & E stain) (200 x, C; 400 x,
D). Clinical disease was scored as followed: 0, healthy; 1, ruffled hair,
hunchbacked or reduced mobility. 2, wasting; 3, limb weakness. 4, limb
paralysis. 5, death. Bars: 1.0 mm. Note moderate emphysema but not
pulmonary edema was observed in the EV71-infected mice (arrowheads).
Additional file 2: Figure 2S. Exogenous IL-13 treatment exacerbated
pulmonary dysfunction in EV71-infected mice. Seven day-old ICR mice
(n = 12) were intracranially inoculated with EV71 (4 × 10
5 PFU/mouse)
followed by an intraperitoneal injection IL-13 at days 3 and 4 post
inoculation. Change in pulmonary functions of mice were monitored daily.
Ctrl: culture medium; BSA: bovine serum albumin; PIF: peak of inspiratory
flow; PEF: peak of expiratory flow; MV: minute volume; TV: tidal volume.
Data represent means ± S.E.M. *, P < 0.05 and **, P <0 . 0 1 .
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